Create a Report

Please provide report title
Please provide location
Please provide details

Get alerts and updates for your case!

This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.

Please provide email or phone
Please provide email or phone

We do not show your email or contact info

Skip this step

Add photos or video

We recommend photos and videos to help explain your report

Add Photo/Video
Skip this step

Email or SMS copy of report

Enter below to get emailed a copy of your report, or sms a link to your report

Please provide email or phone
Please provide email or phone

Thank you for your report!


IMPORTANT - Your report is queued
It may take up to 12 hours to process your report.


Email us at support@safelyhq.com if you have questions.

Report by

Message us
WhatsApp
Loading...
Please provide location
Please provide location
Please provide report title
Please provide details
Please accept our Terms & Conditions
Get alerts and updates for your case! Your contact information is not shown on the website.

This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.

or
Please provide email or phone
Thank you for your report!

IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)

Visit our learn pages for more helpful information or, email us: support@safelyhq.com

Goodbye! and best wishes in your recovery

7300 Medical Center Drive, Los Angeles, California, United States

Updated:

A

Covid-19 OSHA Complaint, HCA West Hills Hospital and Medical Center, 7300 Medical Center Dr., WEST HILLS, CA, 91307, USA

2 years ago

California Code of Regulations, Title 8, Section 5120(c)(5)(C). Health Care Worker Back and Musculoskeletal Injury Prevention. There is no lift equipment or other trained staff available to assist a nurses in pulling up patients in bed, or transferring patients to another bed or chair. California Code of … See More
Regulations. Title 8, Section 5199(e)(l), Aerosol Transmissible Diseases. The Employer does not provide employees with PPE on the Unit. Nurses do not have immediate access to PPE, including N- 95 respirators. The nurses frequently do COVID-19 swabs for pre-op screenings. California Code of Regulations, Title 8, Section 5193(d)(3)(E)(3) and 5193(i). Bloodborne Pathogens. Biohazard trash has not been removed since February 2021. There has been blood product waste in the dirty linen area since the unit was moved to the former L&D Unit. Complainant notes: BBP: Biohazard trash not emptied since February. No PPE on unit. Nurses do not have immediate access to PPE, including N95s. Nurses do COVID-19 swabs for pre­ op screenings. No lift equipment or means for single nurse to assist patients, pull up in bed or transfer to another bed/chair.

Alleged Hazards: 3,
Source: Osha.gov | Receipt Date: 2021-04-08
See Less

#coronaviruscovid19 #osha #blood #7300medicalcenterdrive #losangeles #california #us

468
A

Covid-19 OSHA Complaint, West Hills Hospital and Medical Center, 7300 Medical Center Dr., WEST HILLS, CA, 91307, USA

2 years ago

Employer failed to adhere to health and safety regulations mandating protective measures and plans. ER failed to maintain and supply adequate PPE. Employer failed to provide adequate staff and staffing rations creating unsafe working conditions and inability to monitor and ensure other staff donning and doffing of … See More
PPE. ER failed to comply with or adequately follow mandated Aerosol Transmissible Diseases Exposure Control Plan (ATD) standards. ER unreasonably exposing employees and staff to COVID without adequate safety protocols and PPE. Employer mandated unsafe conduct and procedures related to PPE and denial of use of equipment intended to protect employees from Covid.


Source: Osha.gov | Receipt Date: 2020-12-04
See Less

#coronaviruscovid19 #osha #7300medicalcenterdrive #losangeles #california #us

468
A

Covid-19 OSHA Complaint, HCA West Hills Hospital and Medical Center, 7300 Medical Center Dr., WEST HILLS, CA, 91307, USA

2 years ago

Hospital management failed to follow ATD standards by allowing a COVID positive patient in the Emergency Department wander the ER hallways without being placed in an isolation room. This exposed other patients and staff to COVID.


Source: Osha.gov | Receipt Date: 2020-10-16

#coronaviruscovid19 #osha #7300medicalcenterdrive #losangeles #california #us

468
A

Covid-19 OSHA Complaint, HCA West Hills Hospital and Medical Center, 7300 Medical Center Dr., WEST HILLS, CA, 91307, USA

2 years ago

The hospital failed to follow the ATD standard. Complainant was assigned a COVID-19 positive patient in the Emergency Department that did not go through the normal ER admission Process, not informed of COVID positive status, and not informed that patient was in respiratory distress while also being … See More
assigned to 3 other COVID positive patients.


Source: Osha.gov | Receipt Date: 2020-10-16
See Less

#coronaviruscovid19 #osha #7300medicalcenterdrive #losangeles #california #us

468
A

Covid-19 OSHA Complaint, HCA West Hills Hospital and Medical Center, 7300 Medical Center Dr., WEST HILLS, CA, 91307, USA

2 years ago

The hospital did not provide adequate staff to monitor other staff donning of PPE. The staff of the Telemetry Unit had an inadequate and insufficient supply of PPE. A code blue was initiated on a COVID positive patient. There was insufficient PPE available for the staff and … See More
staff were subsequently exposed to COVID. Hospital management failed to address the urgent need for PPE, including respirators.


Source: Osha.gov | Receipt Date: 2020-10-16
See Less

#coronaviruscovid19 #osha #7300medicalcenterdrive #losangeles #california #us

468
A

Covid-19 OSHA Complaint, West Hills Hospital, 7300 Medical Center Dr., WEST HILLS, CA, 91307, USA

2 years ago

Understaffed in the Covid floor, not getting breaks, not able to follow proper PPE protocols, exposing negative patients to Covid positive floors.

Alleged Hazards: 2, Employees Exposed: 1
Source: Osha.gov | Receipt Date: 2020-09-16

#coronaviruscovid19 #osha #7300medicalcenterdrive #losangeles #california #us

468

Recent Interesting Reports

Dr. Reddy’s Sapropterin Dihydrochloride Powder for Oral Solution - recalled due to decreased potency, USA

4 days ago •source www.fda.gov

Recall notice

Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as "Dr. Reddy's"), today announced that it is voluntarily recalling six (6) lots of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg to the consumer level due to … See More
powder discoloration in some packets leading to decreased potency. The issue was discovered during an accelerated stability test in addition to customer complaints. Sapropterin Dihydrochloride Powder for Oral Solution 100 mg was distributed nationwide to wholesalers/retailers. Dr. Reddy’s Laboratories Inc. has not received any reports of adverse events related to this recall to date.

Reduced efficacy of the product would result in elevated Phenylalaninemia (Phe) levels in patients. Chronically elevated Phe levels in infants and children are likely to cause permanent neurocognitive deficits, including permanent and irreversible intellectual disability, developmental delay, and seizures. Furthermore, elevated Phe levels during pregnancy, especially in early gestation, are associated with microcephaly and congenital heart disease.

The product is indicated to reduce blood phenylalanine (Phe) levels in adult and pediatric patients one month of age and older with hyperphenylalaninemia (HPA) due to tetrahydrobiopterin-(BH4-) responsive Phenylketonuria (PKU) and is packaged in individual packets, 30 per carton. The affected Sapropterin Dihydrochloride Powder for Oral Solution 100mg lots include the following:

- Product Name: Javygtor™ (Sapropterin) Dihydrochloride) Powder for Oral Solution 100 mg, Lot Number: T2202812; T2204053; T2300975; T2300976; T2304356, Expiration date: 07/2025; 10/2025; 02/2026; 02/2026; 08/2026, NDC Number: 43598-097-30; 43598-097-30; 43598-097-30; 43598-097-30; 43598-097-30

- Product Name: Sapropterin Dihydrochloride Powder for Oral Solution 100 mg, Lot Number: T2200352, Expiration date: 12/2024, NDC Number: 43598-477-30

Dr. Reddy’s Laboratories Inc. is notifying its distributors and customers by recall notification letters and is arranging for returns of all recalled products. Anyone with an existing inventory of the product being recalled should examine the product and quarantine any of the recalled lots immediately. Consumers who have Sapropterin Dihydrochloride Powder for Oral Solution 100 mg which is being recalled should contact their physician before stopping use of the product. Consumers who have Sapropterin Dihydrochloride Powder for Oral Solution 100 mg which is being recalled should return it to their place of purchase.

In case you experience harm from this product, it is important to report it. It can help to detect & resolve issues and prevent others from being harmed, and it enables better surveillance. If symptoms persist, seek medical care.

Company name: Dr. Reddy’s Laboratories Inc
Brand name: Dr. Reddy’s
Product recalled: Sapropterin Dihydrochloride Powder for Oral Solution 100 mg
Reason of the recall: Decreased Potency
FDA Recall date: April 23, 2024

Source: www.fda.gov
See Less

#recall #drugs #us

Dr. Reddy’s Sapropterin Dihydrochloride Powder for Oral Solution - recalled due to decreased potency photo #1
303

Tejocote Dietary Supplements - recalled because it contains toxic yellow oleander, USA

2 weeks ago •source www.fda.gov

Recall notice

Global Mix, Inc. of New York, is recalling tejocote products to include the following brands: Eva Nutrition, Science of Alpha, Niwali, NWL Nutra. The recalled products are labeled as tejocote root but are toxic yellow oleander. The recalled products were distributed in the following states: AL, AK, … See More
CA, CO, CT, DE, FL, GA, HI, ID, IL, IA, IN, KS, KY, LA, MD, MA, MI, MN, MS, MO, MT, NE, NV, NM, NC, NY, NJ, ND, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WV, WI, and WY through website. The recalled products were also sold via the below websites via courier direct delivery and mail order. Etsy, amazon, eva-nutrition, tejocotemexican, niwali, scienceofalpha. The recalling firm has not received any reported of illness.

Recalled Products include the following bearing below information. Product codes and expiration dates can be found on the bottom of the packaging.

Product Name: Eva Nutrition MexicanTejocote root, Serial No: 181121U, Mfg Date: 08/01/2023, Expiry Date: 06/2025
Product Name: Science of Alpha Mexican Tejocote root, Serial No: 181121U, Mfg Date: 08/01/2023, Expiry Date: 06/2025
Product Name: NWL Nutra Mexican Tejocote root, Serial No: 181121U, Mfg Date: 08/01/2023, Expiry Date: 06/2025
Product Name: Niwali Mexican Tejocote root, Serial No: 181121U, Mfg Date: 08/01/2023, Expiry Date: 06/2025

Per the safety alert update on 3/12/24, "The FDA continues to receive adverse event reports related to the products identified in this Safety Alert."

The recall was the result of a routine sampling program by the company which revealed that the finished products contained the yellow oleander. The company has ceased the production and distribution of the product as the company continues their investigation as to what caused the problem. Further the company is conducting comprehensive quality control and monitoring process.

Customers who have purchased these products should stop using them immediately and return them to the point of purchase for a full refund.

Ingestion of yellow oleander can cause neurologic, gastrointestinal, and cardiovascular adverse health effects that may be severe, or even fatal. Symptoms may include nausea, vomiting, dizziness, diarrhea, abdominal pain, cardiac changes, dysrhythmia, and more.

If you are experiencing symptoms after eating this product it is important to report it. It can help to detect & resolve outbreaks early and prevent others from being harmed, and it enables better surveillance. If symptoms persist seek medical attention.

Company name: Global Mix, Inc.
Brand name: Eva Nutrition, Science of Alpha, Niwali, NWL Nutra
Product recalled: Tejocote Dietary Supplements
Reason of the recall: Product contains toxic yellow oleander.
FDA Recall date: April 10, 2024

Source: www.fda.gov
See Less

#recall #us

Tejocote Dietary Supplements - recalled because it contains toxic yellow oleander photo #1
303
C

Unauthorized Credit Card Charge from Peggy Piercy, Virginia Beach, VA, USA

3 weeks ago •reported by user-cfjm3464

I received a package containing SUBGENIX BIORIBOSE. MY OLD CARD WAS BILLED FOR THIS I didn't order it. Subsequently my card was cancelled. I'm waiting for my new one. I'm 20lbs under weight, the last thing I need is a weight loss supplement.

#unorderedpackage #delivery #virginiabeach #virginia #us

Unauthorized Credit Card Charge from Peggy Piercy photo #1
582
T

I received a package that I didn't order, the Name on the package is VERDI Bioribose, Tampa, FL, USA

4 weeks ago •reported by user-txfph166

I don't know what happened, All I know is I received an email from my credit union last week asking me if I ordered anything online, and I told them no, and then this week I get this package. The bubble envelope says Fullfillment House PO Box 5708 Tampa FL 33675

#unorderedpackage #delivery #uspostalservice #tampa #florida #us

I received a package that I didn't order, the Name on the package is VERDI Bioribose photo #1
522

Popular topics

#Lifted Boil Water Advisory #Power Outages #Boil Water Advisory #Drugs #Pet Food #Delivery #Starbucks #DreamBone Dog Treats #Online Scam #Unordered Package #Scam #First Energy #PG&E - Pacific Gas and Electric #Facebook Scam #Cedar Grove #Las Vegas
Last 30 days